Duopharma Biotech Berhad (KLSE:DPHARMA)
Malaysia · Delayed Price · Currency is MYR 1.160
-0.010 (-0.85%)
At close: Sep 21, 2026
Duopharma Biotech Berhad Market Cap
Duopharma Biotech Berhad has a market cap or net worth of 1.13 billion as of September 18, 2026. Its market cap has decreased by -13.33% in one year.
Market Cap
1.13B
Enterprise Value
1.34B
Revenue
929.41M
Ranking
n/a
PE Ratio
11.02
Stock Price
1.16
ChartMarket Cap Chart
Since August 27, 2002, Duopharma Biotech Berhad's market cap has increased from 187.00M to 1.13B, an increase of 501.86%. That is a compound annual growth rate of 7.74%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 21, 2026 | 1.13B | -6.40% |
| Dec 31, 2025 | 1.20B | - |
| Dec 31, 2024 | 1.20B | -0.79% |
| Dec 29, 2023 | 1.21B | -20.94% |
| Dec 30, 2022 | 1.53B | -3.10% |
| Dec 31, 2021 | 1.58B | -33.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| DXN Holdings Bhd. | 2.30B |
| Kotra Industries Berhad | 563.59M |
| Y.S.P. Southeast Asia Holding Berhad | 280.85M |
| Sunzen Group Berhad | 178.63M |
| Rhone Ma Holdings Berhad | 149.38M |
| Nova Wellness Group Berhad | 111.55M |
| PeterLabs Holdings Berhad | 61.92M |
| Bioalpha Holdings Berhad | 28.39M |